Related Experiment Videos
Effect of influenza vaccination on plasma phenytoin concentrations
Therapeutic Drug Monitoring
|January 1, 1979
Abstract:
A mean decrease in plasma phenytoin concentrations of 11-14% (p less than 0.005) was observed in seven patients within 4 days after influenza vaccination. Possible mechanisms are discussed.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.
Epilepsy & behavior : E&B·2012
Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
Journal of veterinary internal medicine·2012
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.
Clinical pharmacology and therapeutics·2012
Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
Journal of veterinary pharmacology and therapeutics·2008
Limited Sampling Strategies for Predicting Tacrolimus Systemic Exposure After Adult Kidney Transplantation: A Narrative Review.
Therapeutic drug monitoring·2026
Exploring the Clinical Pharmacokinetics of Sitagliptin in Healthy and Diseased Populations: A Systematic Critical Review.
Therapeutic drug monitoring·2026
KCNA3 Gene Polymorphism Affects the Efficacy and Plasma Concentration of Perampanel in Patients With Refractory Epilepsy.
Therapeutic drug monitoring·2026
Early Tacrolimus Underexposure Predicts Acute Rejection After Renal Transplantation.
Therapeutic drug monitoring·2026
Correlation Between the Extent of Lateral Neck Lymph Node Dissection and Postoperative Parathyroid Function in Papillary Thyroid Carcinoma.
Journal of investigative surgery : the official journal of the Academy of Surgical Research·2026
The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.
Radiology and oncology·2026